BioMarin Pharmaceutical (Nasdaq: BMRN) missed both revenue and earnings estimates in the third quarter, and yet, shares are ...
Foreign investors remain net sellers of Malaysian equities for the third straight week, lifting the year-to-date net ...
There's another plus-sized ute from China, lobbing into the Australian market at an impressively sharp price. But does the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback